Clinical Trial Update: Obe-cel in Refractory Progressive Forms of Multiple Sclerosis [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update indicates Obecel (Obe-cel) for refractory progressive multiple sclerosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progressive Multiple Sclerosis

Drugs mentioned

• obe-cel

Snippet

Sponsor: Autolus Limited | Conditions: Progressive Multiple Sclerosis | Phase 1 | Status: RECRUITING